Axel Gaston Glasmacher
Chairman at 4D PHARMA PLC
Profile
Dr. Axel Gaston Glasmacher, MD, is an Independent Director at Active Biotech AB, a Non-Executive Chairman at 4D Pharma Plc, a General Director at AG Life Science Consulting Gmbh & Co. Kg, a General Director at Glasmacher Verwaltungs GmbH and a Treasurer & Director at The Cancer Drug Development Forum.
He is on the Board of Directors at AvenCell Therapeutics, Inc., Active Biotech AB, Ryvu Therapeutics SA and The Cancer Drug Development Forum.
Dr. Glasmacher was previously employed as a Senior VP-Global Clinical Research & Development by Celgene Corp.
He received his undergraduate degree from the University of Bonn and a doctorate degree from the University of Bonn.
Axel Gaston Glasmacher active positions
| Companies | Position | Start |
|---|---|---|
| 4D PHARMA PLC | Chairman | 2020-04-16 |
| RYVU THERAPEUTICS S.A. | Director/Board Member | 2019-09-30 |
| ACTIVE BIOTECH AB | Director/Board Member | 2019-12-31 |
| The Cancer Drug Development Forum | Director/Board Member | - |
| AG Life Science Consulting Gmbh & Co. Kg | Chief Executive Officer | - |
| Glasmacher Verwaltungs GmbH | Chief Executive Officer | - |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Board Member | 2021-06-30 |
Former positions of Axel Gaston Glasmacher
| Companies | Position | End |
|---|---|---|
| CELGENE | Chief Tech/Sci/R&D Officer | 2018-01-31 |
Training of Axel Gaston Glasmacher
| University of Bonn | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| Private companies | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| The Cancer Drug Development Forum | |
| AG Life Science Consulting Gmbh & Co. Kg | |
| Glasmacher Verwaltungs GmbH | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- Axel Gaston Glasmacher
